Biomarin Pharmaceutical Inc. - Registered Shares

+0.01 (+0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.02B
Current PE16.31
Forward PE N/A
2yr Forward PE 72.72
See more stats
Estimates Current Quarter
Revenue$445.34 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$77.27
50-Day MA$79.78
200-Day MA$87.86
See more pivots

BioMarin Pharmaceutical, Inc. Stock, NASDAQ:BMRN

770 Lindaro Street, San Rafael, California 94901
United States of America
Phone: +1.415.506.6700
Number of Employees: 3001


BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.